🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
This prospective, randomized, controlled, monocentric clinical phase III st...
Status
Unknown
Location
Dept. Radiation Oncology
Start Date
2021-02-01
Trial ID
NCT05160818
The researchers are doing this study to find out if stereotactic body radia...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2021-12-09
Trial ID
NCT05169970
Treatments Being Tested
Patients with high grade brain tumors will be treated to test shortened cou...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2006-04
Trial ID
NCT00386919
Treatments Being Tested
Pancreatic cancer, most commonly adenocarcinoma, is the fourth leading caus...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2016-09-16
Trial ID
NCT03073785
This study is designed to see if we can lower the chance of side effects fr...
Status
Active Not Recruiting
Location
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Start Date
2023-07-11
Trial ID
NCT05703269
The prognosis for patients with metastatic breast cancer has improved conti...
Status
Completed
Location
Universitätsmedizin Mannheim Klinik für Strahlentherapie und Radioonkologie
Start Date
2021-03-05
Trial ID
NCT04495309
Treatments Being Tested
For this study, unfavorable intermediate risk prostate cancer patients will...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-04-16
Trial ID
NCT06397703
Treatments Being Tested
The purpose of this study is to development of more effective treatment tac...
Status
Unknown
Location
National Center of Oncology
Start Date
2013-03
Trial ID
NCT03461822
To derive the maximum tolerated dose of hypofractionated stereotactic body ...
Status
Terminated
Location
Radiotherapy department, University Hospital Ghent
Start Date
2017-07-31
Trial ID
NCT03402737
Treatments Being Tested